Extracellular phytase activity of Bacillus amyloliquefaciens FZB45 contributes to its plant-growth-promoting effect a aThe GenBank accession numbers for the sequences determined in this work are AY055219 to AY055226.

Comparative analysis of the complete genome sequence of the plant growth–promoting bacterium Bacillus amyloliquefaciens FZB42

“…6). A phylogenetic tree constructed from the tetranucleotide usage patterns of genomes of previously sequenced Bacillus strains confirmed that B. amyloliquefaciens FZB42 represents a separate branch, clearly distant from B. subtilis 168 ( Supplementary Fig.…”

“…40). This property was used to generate a set of mutants impaired in many distinct functions, such as production of extracellular enzymes 6 , secondary metabolites 7,8 , biofilm formation, alternative s factors and plant-growth promotion 27 , by a gene-replacement strategy involving homologous recombination. B. amyloliquefaciens FZB42 exhibited its maximal competence somewhat earlier than B. subtilis, during late exponential growth 27 .…”

“…The plant root-colonizing B. amyloliquefaciens strain FZB42 is a naturally occurring isolate, distinguished from the model organism Bacillus subtilis 168 by its abilities to stimulate plant growth and suppress plant pathogens 6 . Previous analyses of this strain revealed numerous gene clusters involved in nonribosomal synthesis of cyclic lipopeptides 7 and polyketides 8 with distinct antimicrobial action.…”

Bacillus amyloliquefaciens bacteriemia in two preterm neonates: A significant catheter-related invasive infection in neonates

“…Few studies also described this organism found on the hands of nursing staff or alcoholic preparation [10]. Also known for his use in biocontrol products [11,12] and probiotics [13], Bacillus amyloliquefaciens is not known as a human pathogen but, in recent years, there has been an increasing appreciation for the potential of Bacillus as opportunistic pathogens in immune-compromised [6,14] or otherwise critically ill patients, those with foreign bodies [15] and intravenous drug abusers as seen with B. cereus [16,17], B. thuringiensis [10] and B. anthracis [18]. Some gastrointestinal infections are also reported with Bacillus species [19,20].…”

Purification and Characterization of α-Amylase from Bacillus subtilis Isolated from Cassava Processing Sites

“…The bacterium was isolated using standard microbiological methods under optimum cultural conditions. α-amylase assay: α-amylase activity was determined as described by Okolo et al [13] with slight modification. The reaction mixture comprising of 2.0 ml of 1% corn starch prepared in 0.5 ml of 0.05 M sodium phosphate buffer (pH 7.0) and 0.5 ml of the supernatant of the crude enzyme extract was used to assay for α-amylase.…”